Charise Gleason
- Oncology top 5%
- Hematology top 2%
- Molecular Biology
- Epidemiology top 10%
- Clinical Biochemistry top 2%
- Co-authors
- Amelia LangstonChristopher R. FlowersKenneth V. I. RolstonEric J. BowDouglas K. HawleySagar LonialJonathan L. KaufmanJennie R. Crews
- Topics
- Multiple Myeloma Research and Treatments (39 papers)Protein Degradation and Inhibitors (24 papers)Cancer Treatment and Pharmacology (14 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Charise Gleason
41 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 966
- Hematology 628
- Molecular Biology 472
- Epidemiology 327
- Clinical Biochemistry 232
Countries citing papers authored by Charise Gleason
This map shows the geographic impact of Charise Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charise Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charise Gleason more than expected).
Fields of papers citing papers by Charise Gleason
This network shows the impact of papers produced by Charise Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charise Gleason. The network helps show where Charise Gleason may publish in the future.
Co-authorship network of co-authors of Charise Gleason
This figure shows the co-authorship network connecting the top 25 collaborators of Charise Gleason. A scholar is included among the top collaborators of Charise Gleason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charise Gleason. Charise Gleason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 19 | |
| 3 | 44 | |
| 4 | 1 | |
| 5 | 34 | |
| 6 | 211 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | 20 | |
| 10 | 1 | |
| 11 | 10 | |
| 12 | 2 | |
| 13 | 142 | |
| 14 | 2 | |
| 15 | 4 | |
| 16 | 85 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | 3 | |
| 20 | 7 |
About Charise Gleason
Charise Gleason is a scholar working on Hematology, Oncology and Molecular Biology, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (39 papers), Protein Degradation and Inhibitors (24 papers) and Cancer Treatment and Pharmacology (14 papers). The work is most often cited by research in Hematology (628 citations), Oncology (966 citations) and Clinical Biochemistry (232 citations). Charise Gleason has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Amelia Langston, Christopher R. Flowers, Kenneth V. I. Rolston, Eric J. Bow, Douglas K. Hawley, Sagar Lonial, Jonathan L. Kaufman, Jennie R. Crews, Randy Taplitz and Erin B. Kennedy. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.